Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant ...
2-Year U.S. Treasury Note Continuous Contract $102.660 0.105 0.10% 5-Year U.S. Treasury Note Continuous Contract $106.234 0.359 0.34% 10-Year U.S. Treasury Note Continuous Contract $108.906 0.641 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback